Cytokine Growth Factor Rev. 2025 Nov 26;87:1. doi: 10.1016/j.cytogfr.2025.11.004. Online ahead of print. NO ABSTRACT PMID:41308274 | DOI:10.1016/j.cytogfr.2025.11.004
Early Hum Dev. 2025 Nov 23;213:106454. doi: 10.1016/j.earlhumdev.2025.106454. Online ahead of print. ABSTRACT OBJECTIVE: To evaluate the suitability (feasibility and ease of use) of a …
Vaccine. 2025 Nov 26;70:128026. doi: 10.1016/j.vaccine.2025.128026. Online ahead of print. ABSTRACT BACKGROUND: To eradicate cervical cancer, the World Health Organization (WHO) targets 90 % human …
J Pediatr Orthop. 2025 Nov 27. doi: 10.1097/BPO.0000000000003171. Online ahead of print. ABSTRACT BACKGROUND: The prevalence of social risk factors in pediatric orthopaedics is underexplored, …
Mol Genet Metab. 2025 Nov 24;146(4):109293. doi: 10.1016/j.ymgme.2025.109293. Online ahead of print. ABSTRACT Glycogen storage disease type IV (GSD IV) is a rare autosomal recessive …
Br J Dermatol. 2025 Nov 27:ljaf481. doi: 10.1093/bjd/ljaf481. Online ahead of print. ABSTRACT BACKGROUND: Extensive and/or atypical dermal melanocytosis (EDM) is abnormal macular blue/black skin …
Br J Dermatol. 2025 Nov 27:ljaf475. doi: 10.1093/bjd/ljaf475. Online ahead of print. ABSTRACT BACKGROUND: Atopic dermatitis (AD) shows characteristics of a systemic disease due to …
Nervenarzt. 2025 Nov 27. doi: 10.1007/s00115-025-01929-0. Online ahead of print. ABSTRACT BACKGROUND: Affective disorders are associated with an enormous disease burden, necessitating research on the …
Schizophr Bull. 2025 Nov 27:sbaf212. doi: 10.1093/schbul/sbaf212. Online ahead of print. ABSTRACT BACKGROUND AND HYPOTHESIS: Cognitive impairment is a core disabling feature of schizophrenia (SZ). …
Eur J Pediatr. 2025 Nov 27;184(12):799. doi: 10.1007/s00431-025-06596-6. ABSTRACT PURPOSE: The second year of life is gaining increased attention in the era of long-acting RSV …
